WINTON GROUP Ltd Grows Position in DENTSPLY SIRONA Inc. $XRAY

WINTON GROUP Ltd grew its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 332.9% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 85,828 shares of the medical instruments supplier’s stock after purchasing an additional 66,000 shares during the period. WINTON GROUP Ltd’s holdings in DENTSPLY SIRONA were worth $981,000 at the end of the most recent quarter.

Other hedge funds have also bought and sold shares of the company. First Eagle Investment Management LLC boosted its position in DENTSPLY SIRONA by 3.2% in the 4th quarter. First Eagle Investment Management LLC now owns 14,640,555 shares of the medical instruments supplier’s stock worth $167,342,000 after purchasing an additional 458,744 shares in the last quarter. Sound Income Strategies LLC lifted its position in shares of DENTSPLY SIRONA by 32.3% during the 4th quarter. Sound Income Strategies LLC now owns 611,308 shares of the medical instruments supplier’s stock valued at $7,464,000 after buying an additional 149,384 shares in the last quarter. Skba Capital Management LLC lifted its position in shares of DENTSPLY SIRONA by 14.3% during the 3rd quarter. Skba Capital Management LLC now owns 1,140,430 shares of the medical instruments supplier’s stock valued at $14,472,000 after buying an additional 142,900 shares in the last quarter. Invenomic Capital Management LP lifted its position in shares of DENTSPLY SIRONA by 48.7% during the 3rd quarter. Invenomic Capital Management LP now owns 4,351,199 shares of the medical instruments supplier’s stock valued at $55,217,000 after buying an additional 1,425,637 shares in the last quarter. Finally, Advisors Asset Management Inc. lifted its position in shares of DENTSPLY SIRONA by 42.8% during the 3rd quarter. Advisors Asset Management Inc. now owns 348,989 shares of the medical instruments supplier’s stock valued at $4,429,000 after buying an additional 104,588 shares in the last quarter. Hedge funds and other institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Stock Up 2.0%

NASDAQ XRAY opened at $10.47 on Wednesday. The business has a fifty day moving average price of $11.07 and a 200 day moving average price of $11.72. DENTSPLY SIRONA Inc. has a one year low of $9.40 and a one year high of $17.09. The company has a debt-to-equity ratio of 1.52, a quick ratio of 0.98 and a current ratio of 1.53. The company has a market cap of $2.10 billion, a P/E ratio of -3.32, a P/E/G ratio of 1.22 and a beta of 0.89.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings data on Tuesday, May 5th. The medical instruments supplier reported $0.27 EPS for the quarter, missing the consensus estimate of $0.28 by ($0.01). DENTSPLY SIRONA had a negative net margin of 17.06% and a positive return on equity of 18.83%. The firm had revenue of $880.00 million during the quarter, compared to analyst estimates of $841.80 million. During the same period in the prior year, the company posted $0.43 earnings per share. The firm’s revenue for the quarter was up .1% compared to the same quarter last year. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. Research analysts anticipate that DENTSPLY SIRONA Inc. will post 1.42 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

XRAY has been the topic of a number of recent analyst reports. Zacks Research upgraded DENTSPLY SIRONA from a “strong sell” rating to a “hold” rating in a research report on Monday, March 2nd. Mizuho decreased their target price on DENTSPLY SIRONA from $16.00 to $14.00 and set a “neutral” rating on the stock in a research report on Wednesday, May 6th. Robert W. Baird increased their target price on DENTSPLY SIRONA from $12.00 to $14.00 and gave the company a “neutral” rating in a research report on Friday, February 27th. Citigroup initiated coverage on DENTSPLY SIRONA in a research report on Wednesday, April 15th. They set a “sell” rating and a $10.00 target price on the stock. Finally, Wells Fargo & Company increased their target price on DENTSPLY SIRONA from $12.00 to $13.00 and gave the company an “equal weight” rating in a research report on Friday, February 27th. Three investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and three have assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $13.55.

DENTSPLY SIRONA Profile

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.